ClinicalTrials.gg
CompletedNCT03252899Updated Aug 17, 2017

Current Practices of Upper Limb Rehabilitation After Stroke

An observational study in Stroke, Upper Extremity Paresis and Survey, sponsored by University Ghent. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-08-17.

Sponsored by University Ghent · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

A survey was conducted among physiotherapists and occupational therapists working with stroke patients. The survey consisted out of 30 questions enquiring personal information and upper limb specific topics divided in 3 sections: (1) Passive mobilization, (2) Active exercises and (3) Immobilization. The survey took approximately 20 to 30 minutes to complete.

The survey for stroke survivors was divided in seven sections: (1) Personal information (2) Motor recovery of the upper limb and expectations on upper limb recovery; (3) Comfort, pain and quality of life (QoL); (4) Immobilization ; (5) Physiotherapy; (6) Occupational therapy; (7) Nursing (only for patients less than 6 months after stroke). The length to complete the survey was also organized to be achieved in 20 to 30 minutes.

02

Conditions studied

  • Stroke
  • Upper Extremity Paresis
  • Survey

Browse trials for

03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's enrollment of 300 is above the median of 152 across 1,968 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University Ghent is the lead sponsor of 350 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Physiotherapists and occupational therapists Stroke survivors with upper limb impairment

Eligibility criteria

Stroke patients

Inclusion Criteria:

  • stroke with upper limb paresis

Exclusion Criteria:

  • severe language or cognitive problems which make it impossible to complete the survey

Therapists

Inclusion Criteria:

  • physiotherapists
  • occupational therapists
  • experienced in the treatment of stroke patients
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
300 participants (actual)
Patient registry
No

Groups and cohorts

  • Therapists

    Physiotherapists/occupational therapists experienced in working with stroke patients.

    Other: Survey therapists

  • Subacute stroke patients

    Stroke patients less than 6 months after their stroke suffering from upper limb paresis.

    Other: Survey patients

  • Chronic stroke patients

    Stroke patients more than 6 months after their stroke suffering from upper limb paresis.

    Other: Survey patients

Interventions

  • OtherSurvey therapists

    A survey was conducted among therapists on upper limb treatment after stroke.

  • OtherSurvey patients

    A survey was conducted among stroke survivors on upper limb treatment after stroke.

06

What researchers measure

Primary outcomes

  1. A questionnaire assessing the current practices of upper limb rehabilitation after stroke

    To identify the current daily practice in stroke rehabilitation concerning upper limb rehabilitation

    Time frame: Dec 2016 - March 2017

  2. A questionnaire assessing the stroke survivors view on upper limb rehabilitation

    To identify the stroke survivors view on upper limb rehabilitation and understanding the patient needs for that matter.

    Time frame: Dec 2016 - March 2017

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2016 to primary completion in Apr 2017, 3 months.

Of 835 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's 3 months is below that.

Counting every sponsor, half of 897 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 4, 2017
First posted
Aug 17, 2017
StartActual
Dec 15, 2016
Primary completionActual
Apr 1, 2017
CompletionActual
Apr 1, 2017
Last update
Aug 17, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03252899
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
Aug 17, 2017
Start date
Dec 15, 2016
Primary completion
Apr 1, 2017
Completion
Apr 1, 2017
Last update
Aug 17, 2017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion